骨髓增生异常综合征的诊治进展

万方数据

万方数据

万方数据

万方数据

万方数据

万方数据

骨髓增生异常综合征的诊治进展

作者：张薇， 邵宗鸿， ZHANG Wei， SHAO Zong-hong

作者单位：天津医科大学总医院血液肿瘤科,天津,300052

刊名：

诊断学理论与实践

英文刊名：JOURNAL OF DIAGNOSTICS CONCEPTS & PRACTICE

年，卷(期)：2010,09(3)

参考文献(49条)

1.Rollison DE;Howlader N;Smith MT Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States,2001-2004,using data from the NAACCR and SEER programs[外文期刊] 2008(01)

2.Valent P;Horny HP;Bennett JM Definitions andstandards in the diagnosis and treatment of the myelodysplastic syndromes:Consensus statements and report from a working conference[外文期刊]

2007(06)

3.何广胜;邵宗鸿骨髓增生异常综合征维也纳诊断标准解读(一)[期刊论文]-中国实用内科杂志 2008(11)

4.Steensma DP;Bennett JM The myelodysplastic syndromes:diagnosis and treatment[外文期刊] 2006(01)

5.Bacher U;Haferlaeh T;Kern W A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia[外文期刊] 2007(06)

6.Nimer SD Myelodysplastic syndromes[外文期刊] 2008(10)

7.Boultwood J;Perry J;Pellagatti A Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia 2010(05)

8.Sridhar K;Ross DT;Tibshirani R Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression[外文期刊] 2009(23)

9.Vasikova A;Budinska E;Belickova M Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome[外文期刊] 2009(04)

10.Cazzola M Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome[外文期刊] 2009(08)

11.Goardon N;Nikolousis E;Sternberg A Reduced CD38 expression on CD34+cells as a diagnostic test in myelodysplastic syndromes 2009(08)

12.Wimazal F;Fonatsch C;Thalhammer R Idiopathic cytopenia of undetermined significance(ICUS)versus low risk MDS:the diagnostic interface[外文期刊] 2007(11)

13.邵宗鸿;付蓉免疫相关性血细胞减少症--一种新认知的疾病(上)[期刊论文]-中国医刊 2005(01)

14.邵宗鸿;付蓉免疫相关性血细胞减少症--一种新认知的疾病(下)[期刊论文]-中国医刊 2005(02)

15.Bennett JM;Catovsky D;Daniel MT Proposals for the classification of the myelodysplastic syndromes 1982(02)

16.Vardiman JW;Harris NL;Brunning RD The World Health Organization(WHO)classification of the myeloid neoplasms[外文期刊] 2002(07)

17.Vardiman JW;Thiele J;Arber DA The 2008 revision of the World Health

Organization(WHO)classification of myeloid neoplasms and acute leukemia:rationale and important changes[外文期刊] 2009(05)

18.Lisa C;Richard AW Iron overload in myelodysplastic syndromes 2009(03)

19.Murphy MF;Wallington TB;Kelsey P Guidelines for the clinical use of red cell transfusions[外文期刊] 2001(01)

20.Porter L;Galancllo R;Saglio G Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox(ICL670):a l-yr prospective study[外文期刊]

2008(02)

21.Taher A;Cappellini MD;Vichinsky E Efficacy and safety of deferasirox doses of》30 ms/kg per d in patients with transfusion-dependent anaemia and iron overload[外文期刊] 2009(05)

22.Greenberg PL;Sun Z;Miller KB Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor:resuits of a prospective randomized phase 3 trial by the Eastern Cooperative Ontology Group(E1996)[外文期刊] 2009(12)

23.Jadersten M;Montgomery SM;Dybedal I Longterm outcome of treatment of anemia in MDS with erythropoietin and G-CSF[外文期刊] 2005(03)

24.J(a)dersten M;Malcovati L;Dybedal I Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic ayndrome[外文期刊] 2008(21)

25.Musto P;Lanza F;Balleari E Darbepoetin alpha for the treatment of anaemia in low-intermediate

risk myelodysplastic syndromes[外文期刊] 2005(02)

26.Gabrilove J;Paquette R;Lyons RM Phase 2,single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes[外文期刊]

2008(03)

27.Kotsianidis I;Bouchliou I;Nakou E Kinetics,function and bone marrow trafficking of CD4+D25+FOXP3+ regulatory T cells in myelodysplastic syndromes(MDS) 2009(03)

28.Garg R;Faded S;Garcia-Manero G Phase Ⅱ study of rabbit anti-thymocyte globulin,cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome 2009(07)

29.Sloand EM;Wu CO;Greenberg P Factors affecting response and survival in patients with myelodysplasiatreated with immonosuppressive therapy[外文期刊] 2008(15)

30.Ishikawa T;Tohyama K;Nakao S A prospective study of cyclospodne A treatment of patients with lowrisk myelodysplastic syndrome:presence of CD55(-)CD59(-)blood cels predicts platelet response[外文期刊] 2007(02)

31.Swerdlow SH;Campo E;Harris NL WHO Classification of Tumours of Haematopoitic and Lymphoid Tissues 2008

32.Raza A;Mehdi M;Mumtaz M Combination of5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia[外文期刊] 2008(07)

33.List A;Dewald G;Bennett J Lenalidomide in the myelodysplastic syndrome with chromosome 5q

deletion[外文期刊] 2006(14)

34.Melchert M;Kale V;List A The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes[外文期刊] 2007(02)

35.List A;Kurtin S;Roe DJ Efficacy of lenalidomide in myelodysplastic syndromes[外文期刊] 2005(06)

36.Raza A;Reeves JA;Feldman EJ Phase 2 study of lenalidomide in transfusion-dependent,low-risk,and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q[外文期刊]

2008(01)

37.Leone G;Teofili L;Voso MT DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias[外文期刊] 2002(12)

38.Kornblith AB;Hemdon JE 2nd;Silverman LR Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phaseⅢ trial:a Cancer and Leukemia Group B study[外文期刊] 2002(10)

39.Silverman LR;McKenzie DR;Peterson BL Further analysis of trials with azacitidine in patients with myelodysplastic syndrome:studies 8421,8921,and 9221by the Cancer and Leukemia Group B[外文期刊] 2006(24)

40.Gurion R;Vidal L;Gaffer-Gvili A5-azacitidine prolongs overall survival in patients with myeledysplastic syndrome-a systematic review and meta-analysis 2010(02)

41.Fenaux P;Mufti GJ;Hellstr(o)m-Lindberg E Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia 2010(04)

42.Kantarjian H;Issa JP;Rosenfeld CS Decitabine improves patient outcomes in myelodysplastic syndromes:results of a phase Ⅲ randomized study[外文期刊] 2006(08)

43.Griffiths EA;Gore SD DNA methyhransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes[外文期刊] 2008(01)

44.Beran M Intensive chemotherapy for patients with hishrisk myelodysplastic syndrome 2000(02)

45.Tricot G;Boogaerts MA The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes 1986(03)

46.Giralt S Bone marrow transplant in myelodysplastic syndromes:new technologies,same questions[外文期刊] 2005(03)

47.Guan M;Chen SC;Go CW Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome:follow-up of 60 cages[期刊论文]-中华医学杂志 2009(13)

48.Nand S;Godwin J;Smith S Hydroxyurea,azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and hish-risk myelodysplastic syndromes in the elderly:results from a pilot trial 2008(11)

49.Zheng WL;Zhang GS;Xu YX Arsenic trioxide,thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients[外文期刊] 2008(02)

本文读者也读过(10条)

1.代志明.夏海龙骨髓增生异常综合征的治疗进展[期刊论文]-安徽医学2010,31(4)

2.肖志坚.XIAO Zhi-jian骨髓增生异常综合征的规范化诊治[期刊论文]-中国实用内科杂志2007,27(14)

3.陈其文.田丹杏.周永明骨髓增生异常综合征治疗进展[期刊论文]-医学研究杂志2010,39(8)

4.金洁.JIN Jie骨髓增生异常综合征研究若干进展[期刊论文]-浙江大学学报（医学版）2006,35(2)

5.丁婕.陈宝安骨髓增生异常综合征治疗研究进展[期刊论文]-临床血液学杂志2009,22(3)

6.施均.邵宗鸿骨髓增生异常综合征疗效评定新标准及治疗研究进展[期刊论文]-中华血液学杂志2003,24(1)

7.赵维莅.ZHAO Wei-li骨髓增生异常综合征的治疗:NCCN与国内经验的比较[期刊论文]-内科理论与实践2009,4(1)

8.于力骨髓增生异常综合征的诊治策略[期刊论文]-中华内科杂志2010,49(3)

9.肖志坚骨髓增生异常综合征的诊断和治疗:第51届美国血液学年会内容简介[期刊论文]-白血病·淋巴瘤2010,19(1)

10.肖志坚依据骨髓增生异常综合征患者预后分组和疗效预测模式选择合适治疗:第52届美国血液学年会报道[期刊论文]-白血病·淋巴瘤2010,19(12)

本文链接：https://www.wendangku.net/doc/6b15482570.html,/Periodical_zdxllysj201003020.aspx